title: Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study.
abstract: OBJECTIVE
  This study evaluates the accuracy of transvaginal ultrasound (TVUS) in combination with CA125 to detect ovarian cancer in women at hereditary risk for ovarian cancer.
  
  
  METHODS
  A semi-annual surveillance protocol comprising CA125 measurement and TVUS was offered to 676 women including 85 BRCA mutation carriers. Surgical intervention was performed if TVUS revealed a suspicious cyst or if elevated CA125 levels or cystic lesions persisted in two consecutive examinations.
  
  
  RESULTS
  Ten women underwent histological verification that revealed one serous cystadenocarcinoma stage Ic. No interval ovarian cancer occurred. The specificity of surgical intervention reached 98.7% (95% confidence interval (CI): 97.5% to 99.3%) and a positive predictive value (PPV) of 10% (95% CI: 1.8% to 40.4%).
  
  
  CONCLUSIONS
  The low PPV is due to the unexpectedly low incidence of ovarian cancer. Large scale investigations including details on potential confounders and modifiers are needed to further evaluate accuracy and effectiveness of ovarian cancer screening for women at high risk.
authors.affiliation: Division of Molecular Gyneco-Oncology, Department for Obstetrics and Gynecology, University of Cologne, Germany.
authors.forename: Kristin
authors.initials: K
authors.lastname: Bosse
authors.forename: Kerstin
authors.initials: K
authors.lastname: Rhiem
authors.forename: Barbara
authors.initials: B
authors.lastname: Wappenschmidt
authors.forename: Martin
authors.initials: M
authors.lastname: Hellmich
authors.forename: Martin
authors.initials: M
authors.lastname: Madeja
authors.forename: Monika
authors.initials: M
authors.lastname: Ortmann
authors.forename: Peter
authors.initials: P
authors.lastname: Mallmann
authors.forename: Rita
authors.initials: R
authors.lastname: Schmutzler
mesh_terms: D000328:Adult; D018394:CA-125 Antigen / Q000097:blood*; D015331:Cohort Studies; D018284:Cystadenocarcinoma, Serous / Q000097:blood / Q000000981:diagnostic imaging / Q000235:genetics / Q000473:pathology; D003663:Decision Trees; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D008403:Mass Screening / Q000379:methods; D008875:Middle Aged; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000097:blood* / Q000000981:diagnostic imaging* / Q000235:genetics / Q000473:pathology / Q000517:prevention & control; D011237:Predictive Value of Tests; D011446:Prospective Studies; D014463:Ultrasonography / Q000379:methods; D014621:Vagina
chemical_list: D018394:CA-125 Antigen